Clinical Effect of Double Level Positive Airway Pressure Joint Pumping Respiratory Stimulant in Treating Chronic Obstructive Pulmonary Disease Patients with Type II Respiratory Failure

Objective To explore the clinical effect of double level positive airway pressure( Bi PAP) joint pumping respiratory stimulant in treating chronic obstructive pulmonary disease( COPD) patients with typeⅡrespiratory failure. Methods A total of 66 COPD patients with type Ⅱ respiratory failure were selected in the Changqing Oilfield workers' Hospital from January 2014 to January 2015,they were divided into control group and observation group,each of 33 cases according to the treatment sequence. On the basis of routine treatment,patients in control group were treated with Bi PAP,while the patients in observation group were treated with Bi PAP joint pumping respiratory stimulant. The clinical effect and incidence of adverse reactions,basic physiological index before and after treatment were compared between the two groups. Results Before and after the treatment,no statistically significant differences of SBP,DBP,HR and RR was found between the two groups( P 0. 05);After treatment,the SBP,DBP,HR and RR of the two groups were statistically significantly lower than that of before( P 0. 05). Before treatment, no statistically significant differences of Pa O2,Sa O2,Pa CO2 and p H was found between the two groups( P 0. 05); After treatment,the Pa O2,Sa O2,p H of observation group were statistically significantly higher than that of control group,and Pa CO2 was statistically significantly lower than that of control group( P 0. 05); After treatment,the Pa O2,Sa O2,p H of the two groups were statistically significantly higher than that of before,and Pa CO2 of the two groups was statistically significantly lower than that of before( P 0. 05). The clinical effect of observation group was statistically significantly better than that of control group( P 0. 05). The incidence of adverse reactions of observation group was statistically significantly lower than that of control group( P 0. 05). Conclusion The clinical effect of Bi PAP joint pumping respiratory stimulant in treating chronic obstructive pulmonary disease patients with type Ⅱ respiratory failure is exactly, it can improve the ventilation condition,and can reduce the incidence of adverse reactions.